These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31783869)

  • 21. Golden Gate-based metabolic engineering strategy for wild-type strains of Yarrowia lipolytica.
    Egermeier M; Sauer M; Marx H
    FEMS Microbiol Lett; 2019 Feb; 366(4):. PubMed ID: 30698703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome Editing, Transcriptional Regulation, and Forward Genetic Screening Using CRISPR-Cas12a Systems in Yarrowia lipolytica.
    Ramesh A; Lee S; Wheeldon I
    Methods Mol Biol; 2024; 2760():169-198. PubMed ID: 38468089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expansion of YALIcloneHR toolkit for Yarrowia lipolytica combined with Golden Gate and CRISPR technology.
    Shen Q; Yan F; Li YW; Wang J; Ji J; Yan WX; He DC; Song P; Shi TQ
    Biotechnol Lett; 2024 Feb; 46(1):37-46. PubMed ID: 38064043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic engineering in the host Yarrowia lipolytica.
    Abdel-Mawgoud AM; Markham KA; Palmer CM; Liu N; Stephanopoulos G; Alper HS
    Metab Eng; 2018 Nov; 50():192-208. PubMed ID: 30056205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in construction and regulation of yeast cell factories.
    Jiao X; Gu Y; Zhou P; Yu H; Ye L
    World J Microbiol Biotechnol; 2022 Feb; 38(4):57. PubMed ID: 35174424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A CRISPR/Cas9-Mediated, Homology-Independent Tool Developed for Targeted Genome Integration in Yarrowia lipolytica.
    Cui Z; Zheng H; Zhang J; Jiang Z; Zhu Z; Liu X; Qi Q; Hou J
    Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33452022
    [No Abstract]   [Full Text] [Related]  

  • 27. Holistic Approaches in Lipid Production by Yarrowia lipolytica.
    Lazar Z; Liu N; Stephanopoulos G
    Trends Biotechnol; 2018 Nov; 36(11):1157-1170. PubMed ID: 30006239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guide RNA Design for Genome-Wide CRISPR Screens in Yarrowia lipolytica.
    Ramesh A; Wheeldon I
    Methods Mol Biol; 2021; 2307():123-137. PubMed ID: 33847986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in synthetic biology tools paving the way for the biomanufacturing of unusual fatty acids using the Yarrowia lipolytica chassis.
    Wang K; Shi TQ; Lin L; Wei P; Ledesma-Amaro R; Ji XJ; Huang H
    Biotechnol Adv; 2022 Oct; 59():107984. PubMed ID: 35609800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic Engineering of
    Zhang TL; Yu HW; Ye LD
    ACS Synth Biol; 2023 Mar; 12(3):639-656. PubMed ID: 36867718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding Functional Roles of Native Pentose-Specific Transporters for Activating Dormant Pentose Metabolism in Yarrowia lipolytica.
    Ryu S; Trinh CT
    Appl Environ Microbiol; 2018 Feb; 84(3):. PubMed ID: 29150499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic engineering of
    Zhang G; Wang H; Zhang Z; Verstrepen KJ; Wang Q; Dai Z
    Crit Rev Biotechnol; 2022 Jun; 42(4):618-633. PubMed ID: 34325575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-scale model-driven strain design for dicarboxylic acid production in Yarrowia lipolytica.
    Mishra P; Lee NR; Lakshmanan M; Kim M; Kim BG; Lee DY
    BMC Syst Biol; 2018 Mar; 12(Suppl 2):12. PubMed ID: 29560822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Broadening the application of
    Park YK; Rossignol T
    Microbiology (Reading); 2024 Jun; 170(6):. PubMed ID: 38913407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic engineering for increased lipid accumulation in Yarrowia lipolytica - A Review.
    Wang J; Ledesma-Amaro R; Wei Y; Ji B; Ji XJ
    Bioresour Technol; 2020 Oct; 313():123707. PubMed ID: 32595069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yarrowia lipolytica: recent achievements in heterologous protein expression and pathway engineering.
    Madzak C
    Appl Microbiol Biotechnol; 2015 Jun; 99(11):4559-77. PubMed ID: 25947247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Advances in metabolic engineering of non-conventional yeasts].
    Su L; Zhang G; Yao Z; Liang P; Dai Z; Wang Q
    Sheng Wu Gong Cheng Xue Bao; 2021 May; 37(5):1659-1676. PubMed ID: 34085448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A teaching protocol demonstrating the use of EasyClone and CRISPR/Cas9 for metabolic engineering of Saccharomyces cerevisiae and Yarrowia lipolytica.
    Milne N; Tramontin LRR; Borodina I
    FEMS Yeast Res; 2020 Mar; 20(2):. PubMed ID: 31556952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Production of carboxylic acids by metabolically engineered
    Rong L; Liu S; Zhu K; Kong J; Miao L; Wang S; Xiao D; Yu A
    Sheng Wu Gong Cheng Xue Bao; 2022 Apr; 38(4):1360-1372. PubMed ID: 35470612
    [No Abstract]   [Full Text] [Related]  

  • 40. Gene repression via multiplex gRNA strategy in Y. lipolytica.
    Zhang JL; Peng YZ; Liu D; Liu H; Cao YX; Li BZ; Li C; Yuan YJ
    Microb Cell Fact; 2018 Apr; 17(1):62. PubMed ID: 29678175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.